Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

Rhea-AI Summary

Resmed (NYSE: RMD) will report first quarter fiscal 2026 results on Thursday, October 30, 2025 after NYSE close. Management will host a live webcast at 1:30 p.m. PDT / 4:30 p.m. EDT (London 8:30 p.m. GMT; Sydney Oct 31 7:30 a.m. AEDT) to discuss financial and operational results and other material information.

Investors can access the webcast at https://investor.resmed.com. A replay will be available on the investor relations site about two hours after the webcast. A phone replay runs from October 30, 2025 through November 13, 2025 with U.S. and international dial-ins and conference ID 13756529.

SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

	•	Location:	https://investor.resmed.com
	•	Date:	Thursday, October 30, 2025
	•	Time:	1:30 p.m. PDT / 4:30 p.m. EDT
	•	International:	London, Thursday, October 30, 2025, 8:30 p.m. GMT Sydney, Friday, October 31, 2025, 7:30 a.m. AEDT

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 30, 2025, until November 13, 2025, at:

	•	U.S.: +1 877.660.6853
	•	International: +1 201.612.7415
	•	Conference ID: 13756529

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investors  +1 858.221.3304  investorrelations@Resmed.com

For media +1 619.510.1281 news@Resmed.com

FAQ

When will Resmed (RMD) report Q1 fiscal 2026 earnings?

Resmed will release Q1 fiscal 2026 results on Thursday, October 30, 2025 after the NYSE closes.

What time is the Resmed (RMD) earnings webcast on October 30, 2025?

The live webcast is scheduled for 1:30 p.m. PDT / 4:30 p.m. EDT (London 8:30 p.m. GMT; Sydney Oct 31 7:30 a.m. AEDT).

Where can investors watch the Resmed (RMD) Q1 FY2026 webcast?

Watch the webcast at https://investor.resmed.com via the company’s investor relations website.

When will the replay of Resmed's (RMD) earnings webcast be available?

A replay will be available on the investor relations site approximately two hours after the webcast ends.

How can I access the phone replay for Resmed (RMD) Q1 FY2026 results?

Phone replay is available from Oct 30 through Nov 13, 2025. U.S. dial-in: +1 877.660.6853; International: +1 201.612.7415; Conference ID: 13756529.

Will Resmed (RMD) use an outside phone line for the live earnings call?

No. Resmed stated the earnings call is accessible only via the webcast link and does not use outside phone lines for live access.